封面
市場調查報告書
商品編碼
1679409

美國動物照護現場診斷市場規模、佔有率、趨勢分析報告,按產品類型、動物類型、樣本類型、適應症、測試類別、最終用途、國家/地區、細分市場預測,2025 年至 2030 年

U.S. Veterinary Point of Care Diagnostics Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Sample Type, By Indication, By Testing Category, By End-Use, By Country, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

市場規模和趨勢

預計 2024 年美國獸醫照護現場診斷市場價值將達到 10.4 億美元,2025 年至 2030 年的複合年成長率為 9.2%。

推動市場成長的關鍵因素是寵物相關產品和服務支出的快速增加、寵物飼主數量的增加、技術進步以及對照護現場診斷的強勁需求。

伴同性動物數量的成長預計將推動獸醫醫療服務的需求並增加整體寵物支出。根據美國寵物產品協會 (APPA) 發布的 2024 年統計數據,美國寵物主人在寵物身上的花費預計將超過 1500 億美元,比 2018 年的 905 億美元成長約 66%。此外,預計 2024 年家庭寵物飼主在獸醫服務和產品上的花費約為 390 億美元。類似照護現場(POC) 的診斷測試無需核心診斷實驗室即可提供即時結果和臨床相關資訊。這減少了與獸醫診斷相關的成本和時間。橫向流動技術,例如 POC 獸醫橫向流動裝置和試紙,幾十年來一直用於診斷動物感染疾病。

此外,大量的獸醫診所就診患者和發達的獸醫醫療基礎設施預計將進一步促進市場發展。公司正在投資研發以開發照護現場診斷設備。例如,IDEXX 開發了一種 SDMA檢測套組,使用 AI 來評估狗和貓的腎臟功能。碩騰計劃在未來幾年內推出一系列照護現場診斷產品。 Heska 也推出了一系列照護現場診斷產品來補充其產品組合。

推動診斷領域持續發展的另一個驅動力是動物照護現場診斷新技術的出現。例如,哈佛大學 Wyss 實驗室的研究人員開發了 directEsense,照護現場診斷技術。該技術利用生物感測器表面的電活性化學層直接檢測疾病生物標記或病原體,簡化了診斷過程,無需檢測標籤。本研究重點在於檢測患有肌肉骨骼損傷和感染疾病的伴同性動物中特定的循環血清蛋白。兩家公司目前正在尋求高效的產品開發以及在人類和環境健康診斷領域的潛在未來應用。

此外,其他一些進步如人​​工智慧(AI)也有望成為未來產業成長的催化劑,人工智慧透過即時分析X光和血液測試等醫療資料來提高診斷的速度和準確性。分子診斷透過識別特定病原體和遺傳標記來促進疾病的早期發現,從而為每隻動物提供個人化醫療。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章美國動物照護現場診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素分析
    • 寵物相關支出增加
    • 技術進步
    • 對照護現場的需求不斷成長
    • 牲畜和寵物數量增加
  • 市場限制因素分析
    • 已開發市場與新興市場之間的經濟差距
    • 規章制度鬆散且不規範
    • 研發流程漫長,投入龐大
  • 產業分析—波特五力分析
    • 供應商權力
    • 買方力量
    • 替代威脅
    • 新進入者的威脅
    • 競爭對手之間的競爭
  • PESTEL分析
    • 政治
    • 科技
    • 經濟
  • 技術演進分析
  • 2018-2024年主要物種動物族群數量估計
  • 監管情景
  • COVID-19影響分析

第4章。美國動物照護現場診斷市場(按產品、估計和趨勢分析)

  • 美國動物照護現場診斷市場產品儀表板
  • 美國動物照護現場診斷市場產品差異分析
  • 2018-2030年美國動物照護現場診斷市場規模、預測及趨勢分析
  • 耗材、試劑和套件
  • 2018-2030年耗材、試劑及套件市場預測及預測
    • 設備和裝置
    • 2018-2030年設備與器材市場估計與預測

第5章。美國動物照護現場診斷市場(按動物類型、展望、估計和趨勢分析)

  • 美國動物照護現場診斷動物型模型儀表板
  • 美國動物照護現場診斷市場動物類型變異分析
  • 家畜
  • 家禽
  • 其他
  • 寵物
  • 其他

第6章。美國動物照護現場診斷市場(按樣本類型、估計和趨勢分析)

  • 美國動物照護現場診斷樣本類型模型儀表板
  • 美國動物照護現場診斷市場樣本類型差異分析
  • 血液/血漿/血清
    • 2018-2030年血液/血漿/血清市場估計與預測
  • 尿
    • 2018-2030年尿液市場估計與預測
    • 2018-2030年糞便市場估計與預測
  • 其他
    • 2018-2030年其他市場估計與預測

第7章。美國動物照護現場診斷市場,按適應症、估計和趨勢分析

  • 美國動物照護現場指徵的模型儀表板
  • 美國動物照護現場診斷市場適應症變化分析
  • 感染疾病
    • 2018-2030年感染疾病市場估計與預測
  • 一般疾病
    • 2018-2030年一般疾病市場估計與預測
  • 其他
    • 2018-2030年其他市場估計與預測

第8章美國動物照護現場診斷市場(按測試類別、估計和趨勢分析)

  • 美國動物照護現場診斷測試類別儀表板
  • 美國動物照護現場診斷市場檢測類別變化分析
  • 測試類別儀表板
  • 血液學
    • 2018-2030年血液學市場估計與預測
  • 診斷影像
    • 2018-2030年診斷影像市場估計與預測
  • 細菌學
    • 2018-2030年細菌學市場估計與預測
  • 病毒學
    • 2018-2030年病毒學市場估計與預測
  • 細胞學
    • 2018-2030年細胞學市場估計與預測
  • 臨床化學
    • 2018-2030年臨床化學市場估計與預測
  • 寄生蟲學
    • 2018-2030年寄生蟲學市場估計與預測
  • 血清學
    • 2018-2030年血清學市場估計與預測
  • 其他
    • 2018-2030年其他市場估計與預測

第9章美國動物照護現場診斷市場(按最終用途、估計和趨勢分析)

  • 美國動物照護現場診斷最終用途模型儀表板
  • 美國動物照護現場診斷市場最終用途差異分析
  • 動物醫院診所
    • 2018-2030年獸醫診所市場估計與預測
  • 居家醫療
    • 2018-2030 年居家醫療市場估計與預測
  • 其他
    • 2018-2030年其他市場估計與預測

第10章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
    • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • 主要客戶
    • 2024年主要企業市場佔有率分析
  • Zoetis Inc.
  • Thermo Fisher Scientific Inc
  • Heska Corporation
  • Phibro Animal Health Corporation
  • Blair Milling and Elevator Co., Inc.
  • NeuroLogica Corp
  • NEOGEN Corporation
  • Marshfield Labs
  • ProtaTek International, Inc.
  • Texas A& M Veterinary Medical Diagnostic Laboratory
  • VCA, Inc
  • IDEXX
  • University of Minnesota
Product Code: GVR-4-68040-227-3

Market Size & Trends:

The U.S. veterinary point-of-care diagnostics market size was valued at USD 1.04 billion in 2024 and is estimated to grow at a CAGR of 9.2% from 2025 to 2030. The market's growth is predominantly fueled by a surge in spending on pet-related products and services, an expanding number of pet owners, technological advancements, and a strong demand for point-of-care diagnostics.

The rise in the companion animal population is anticipated to drive demand for veterinary healthcare services and increase overall pet spending. Pet owners in the U.S., according to 2024 statistics published by the American Pet Products Association (APPA), are estimated to be spending more than USD 150 billion on their pets, about a 66% rise from the USD 90.5 billion expenditure in 2018. Furthermore, pet owners in the country are estimated to spend about USD 39 billion on veterinary care services & products in 2024. Diagnostic tests like point-of-care (POC) provide immediate results and clinically relevant information without needing a core diagnostic laboratory. Therefore, they can reduce the cost and time associated with veterinary diagnosis. The lateral flow technology applied in POC veterinary lateral flow devices and dipsticks has been used for decades to diagnose infectious diseases among animals.

Moreover, the high number of veterinary patient visits and developed veterinary healthcare infrastructure are further expected to fuel the market growth. Companies are investing in R&D to develop point-of-care diagnostic equipment. For instance, IDEXX developed SDMA test kits, which use AI to assess kidney functions in cats and dogs. Zoetis has a pipeline of point-of-care diagnostics, which is expected to be launched in the coming years. Heska also launched a range of point-of-care diagnostic products to broaden its portfolio.

Another continuously evolving driver of this diagnostic sector is the emergence of novel technologiesfor advancing POC diagnostics in animals. For instance, researchers from Wyss Research Institute at Harvard College have developed a POC diagnostic technology, directEsense, for application in veterinary health. The technology simplifies the diagnostic process by utilizing an electrically active chemical layer on biosensor surfaces to directly detect disease biomarkers and pathogens and eliminates the need for detection labels; this product enhances electrical conductivity and reduces costs associated with traditional diagnostic methods. This research focuses on detecting unique blood serum proteins in companion animals suffering from musculoskeletal injuries and infections. The parties are now aiming for efficient product development and potential future human and environmental health diagnostics applications.

Furthermore, some other advancements, like artificial intelligence (AI), which enhances the speed and accuracy of diagnoses through real-time analysis of medical data, such as X-rays and blood tests, are expected to act as catalysts for future industry growth. Molecular diagnostics facilitate early disease detection by identifying specific pathogens and genetic markers, facilitating personalized medicine tailored to individual animals.

U.S. Veterinary Point of Care Diagnostics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the U.S. intravenous infusion pump market based on product, animal type, sample type, indication, testing category, and end-use:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Consumables, Reagents, & Kits
  • Instruments & Devices
  • Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Others
  • Livestock Animals
    • Cattle
    • Swine
    • Poultry
  • Sample Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Blood/Plasma/Serum
  • Urine
  • Fecal
  • Others
  • Indication Outlook (Revenue, USD Million, 2018 - 2030)
  • Infectious Disease
  • General Ailments
  • Others
  • Testing Category Outlook (Revenue, USD Million, 2018 - 2030)
  • Hematology
  • Diagnostic Imaging
  • Bacteriology
  • Virology
  • Cytology
  • Clinical Chemistry
  • Parasitology
  • Serology
  • Others
  • End-Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Veterinary Hospitals & Clinics
  • Home Care Settings
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal Type
    • 1.2.3. Sample Type
    • 1.2.4. Indication
    • 1.2.5. Testing category
    • 1.2.6. End-use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in Italy
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product
    • 2.2.2. Disease Indication
  • 2.3. Competitive Insights

Chapter 3. U.S. Veterinary point of care diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
  • 3.3. Market Driver Analysis
    • 3.3.1. Increasing Pet-Related Expenditures
    • 3.3.2. Technological Advancements
    • 3.3.3. Increasing Demand for Point-Of-Care Diagnostics
    • 3.3.4. Rising Livestock Population and Pet Ownership
  • 3.4. Market Restraint Analysis
    • 3.4.1. Economic Differences in Developed & Developing Markets
    • 3.4.2. Unstructured And Lenient Rules & Regulations
    • 3.4.3. Time-Consuming R&D Processes and Higher Investments
  • 3.5. Industry Analysis - Porter's Five Forces
    • 3.5.1. Supplier power
    • 3.5.2. Buyer power
    • 3.5.3. Substitution threat
    • 3.5.4. Threat of new entrant
    • 3.5.5. Competitive rivalry
  • 3.6. PESTEL Analysis
    • 3.6.1. Political landscape
    • 3.6.2. Technological landscape
    • 3.6.3. Economic Landscape
  • 3.7. Technology Evolution Analysis
  • 3.8. Estimated Animal Population, by Key Species, 2018 - 2024
  • 3.9. Regulatory Scenario
  • 3.10. COVID-19 Impact Analysis

Chapter 4. U.S. Veterinary point of care diagnostics Market Product Estimates & Trend Analysis

  • 4.1. U.S. Veterinary point of care diagnostics Market Product Dashboard
  • 4.2. U.S. Veterinary point of care diagnostics Market Product Movement Analysis
  • 4.3. U.S. Veterinary point of care diagnostics Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.4. Consumables, Reagents, & Kits
  • 4.5. Consumables, Reagents, & Kits Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 4.5.1. Instruments & Devices
    • 4.5.2. Instruments & Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. U.S. Veterinary point of care diagnostics Market: Animal Type Outlook Estimates & Trend Analysis

  • 5.1. U.S. Veterinary point of care diagnostics Animal Type Model Dashboard
  • 5.2. U.S. Veterinary point of care diagnostics Market Animal Type Movement Analysis
  • 5.3. Livestock
    • 5.3.1. Livestock Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Poultry
    • 5.4.1. Poultry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cattle
    • 5.5.1. Cattle Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Swine
    • 5.6.1. Swine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Companion Animals
    • 5.8.1. Companion Animals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Dogs
    • 5.9.1. Dogs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Cats
    • 5.10.1. Cats Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Horses
    • 5.11.1. Horses Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.12. Others
    • 5.12.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Veterinary point of care diagnostics Market Sample Type Estimates & Trend Analysis

  • 6.1. U.S. Veterinary point of care diagnostics Sample Type Model Dashboard
  • 6.2. U.S. Veterinary point of care diagnostics Market Sample Type Movement Analysis
  • 6.3. Blood/Plasma/Serum
    • 6.3.1. Blood/Plasma/Serum Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Urine
    • 6.4.1. Urine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Fecal
    • 6.5.1. Fecal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Veterinary point of care diagnostics Market Indication Estimates & Trend Analysis

  • 7.1. U.S. Veterinary point of care diagnostics Indication Model Dashboard
  • 7.2. U.S. Veterinary point of care diagnostics Market Indication Movement Analysis
  • 7.3. Infectious Disease
    • 7.3.1. Infectious Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. General Ailments
    • 7.4.1. General Ailments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. U.S. Veterinary point of care diagnostics Market Testing Category Estimates & Trend Analysis

  • 8.1. U.S. Veterinary point of care diagnostics Testing Category Model Dashboard
  • 8.2. U.S. Veterinary point of care diagnostics market testing Category Movement Analysis
  • 8.3. Testing Category Dashboard
  • 8.4. Hematology
    • 8.4.1. Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Diagnostic Imaging
    • 8.5.1. Diagnostic Imaging Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Bacteriology
    • 8.6.1. Bacteriology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Virology
    • 8.7.1. Virology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Cytology
    • 8.8.1. Cytology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9. Clinical Chemistry
    • 8.9.1. Clinical Chemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.10. Parasitology
    • 8.10.1. Parasitology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11. Serology
    • 8.11.1. Serology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.12. Others
    • 8.12.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. U.S. Veterinary point of care diagnostics Market End-use Estimates & Trend Analysis

  • 9.1. U.S. Veterinary point of care diagnostics Testing Category Model Dashboard
  • 9.2. U.S. Veterinary point of care diagnostics market testing Category Movement Analysis
  • 9.3. Veterinary Hospitals & Clinics
    • 9.3.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Home Care Settings
    • 9.4.1. Home Care Settings Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Others
    • 9.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
    • 10.2.1. Vendor Landscape
    • 10.2.2. List of key distributors and channel partners
    • 10.2.3. Key customers
    • 10.2.4. Key company market share analysis, 2024
  • 10.3. Zoetis Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Strategic initiatives
  • 10.4. Thermo Fisher Scientific Inc
    • 10.4.1. Company Overview
    • 10.4.2. Financial performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Strategic initiatives
  • 10.5. Heska Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Strategic initiatives
  • 10.6. Phibro Animal Health Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financial performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Strategic initiatives
  • 10.7. Blair Milling and Elevator Co., Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Strategic initiatives
  • 10.8. NeuroLogica Corp
    • 10.8.1. Company Overview
    • 10.8.2. Financial performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Strategic initiatives
  • 10.9. NEOGEN Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Strategic initiatives
  • 10.10. Marshfield Labs
    • 10.10.1. Company Overview
    • 10.10.2. Financial performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Strategic initiatives
  • 10.11. ProtaTek International, Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Strategic initiatives
  • 10.12. Texas A&M Veterinary Medical Diagnostic Laboratory
    • 10.12.1. Company Overview
    • 10.12.2. Financial performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Strategic initiatives
  • 10.13. VCA, Inc
    • 10.13.1. Company Overview
    • 10.13.2. Financial performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Strategic initiatives
  • 10.14. IDEXX
    • 10.14.1. Company Overview
    • 10.14.2. Financial performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Strategic initiatives
  • 10.15. University of Minnesota
    • 10.15.1. Company Overview
    • 10.15.2. Financial performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. Veterinary Point of Care diagnostics, By Product, 2018 - 2030 (USD Billion)
  • Table 3 U.S. Veterinary point of care diagnostics, By Animal Type, 2018 - 2030 (USD Billion)
  • Table 4 U.S. Veterinary point of care diagnostics, By Companion Animals, 2018 - 2030 (USD Billion)
  • Table 5 U.S. Veterinary point of care diagnostics, By Livestock Animals, 2018 - 2030 (USD Billion)
  • Table 6 U.S. Veterinary point of care diagnostics, By Sample Type, 2018 - 2030 (USD Billion)
  • Table 7 U.S. Veterinary point of care diagnostics, By Testing Category, 2018 - 2030 (USD Billion)
  • Table 8 U.S. Veterinary Point of Care diagnostics, By Indication, 2018 - 2030 (USD Billion)
  • Table 9 U.S. Veterinary point of care diagnostics, By End-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Veterinary point of care diagnostics Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 U.S. Veterinary point of care diagnostics Market: Product outlook and key takeaways
  • Fig. 15 U.S. Veterinary point of care diagnostics Market: Product movement analysis & market share 2023 & 2030
  • Fig. 16 Consumables, Reagents, & Kits market, 2018-2030 (USD Billion)
  • Fig. 17 Instruments & Devices market, 2018 - 2030 (USD Million)
  • Fig. 18 Veterinary point of care diagnostics Market: Animal Type outlook and key takeaways
  • Fig. 19 Veterinary point of care diagnostics Market: Animal Type movement analysis & market share 2023 & 2030
  • Fig. 20 Livestock Animals market, 2018 - 2030 (USD Million)
  • Fig. 21 Poultry market, 2018 - 2030 (USD Million)
  • Fig. 22 Cattle market, 2018 - 2030 (USD Million)
  • Fig. 23 Swine market, 2018 - 2030 (USD Million)
  • Fig. 24 Others market, 2018 - 2030 (USD Million)
  • Fig. 25 Companion Animals market, 2018 - 2030 (USD Million)
  • Fig. 26 Dogs market, 2018 - 2030 (USD Million)
  • Fig. 27 Cats market, 2018 - 2030 (USD Million)
  • Fig. 28 Horses market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Veterinary point of care diagnostics Market: Testing category outlook and key takeaways
  • Fig. 31 Veterinary point of care diagnostics Market: Testing category movement analysis & market share
  • Fig. 32 Haematology market, 2018 - 2030 (USD Million)
  • Fig. 33 Diagnostic Imaging Market, 2018 - 2030 (USD Million)
  • Fig. 34 Bacteriology market, 2018 - 2030 (USD Million)
  • Fig. 35 Virology market, 2018 - 2030 (USD Million)
  • Fig. 36 Cytology market, 2018 - 2030 (USD Million)
  • Fig. 37 Clinical Chemistry Market, 2018 - 2030 (USD Million)
  • Fig. 38 Parasitology market, 2018 - 2030 (USD Million)
  • Fig. 39 Serology market, 2018 - 2030 (USD Million)
  • Fig. 40 Others market, 2018 - 2030 (USD Million)
  • Fig. 41 Veterinary point of care diagnostics Market: Indication outlook and key takeaways
  • Fig. 42 Veterinary point of care diagnostics Market: Indication movement analysis & market share
  • Fig. 43 Infectious Disease Market, 2018 - 2030 (USD Million)
  • Fig. 44 General Ailments market, 2018 - 2030 (USD Million)
  • Fig. 45 Others market, 2018 - 2030 (USD Million)
  • Fig. 46 Veterinary point of care diagnostics Market: Sample type outlook and key takeaways
  • Fig. 47 Veterinary point of care diagnostics Market: Sample type movement analysis & market share
  • Fig. 48 Blood/Plasma/Serum market, 2018 - 2030 (USD Million)
  • Fig. 49 Urine market, 2018 - 2030 (USD Million)
  • Fig. 50 Faecal market, 2018 - 2030 (USD Million)
  • Fig. 51 Others market, 2018 - 2030 (USD Million)
  • Fig. 52 Veterinary point of care diagnostics Market: End-use outlook and key takeaways
  • Fig. 53 Veterinary point of care diagnostics Market: End-use movement Analysis & market share
  • Fig. 54 Veterinary Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 55 Home Care Settings market, 2018 - 2030 (USD Million)
  • Fig. 56 Others market, 2018 - 2030 (USD Million)